Cargando...

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could BCHE Genotyping Be Helpful in Alzheimer’s Therapy?

Late-onset Alzheimer’s disease (AD) is clinically characterized by a progressive decline of memory and other cognitive functions leading to the loss of the ability to perform everyday activities. Only a few drugs have been approved to treat AD dementia over the past century since the first AD patien...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biomolecules
Main Authors: Jasiecki, Jacek, Wasąg, Bartosz
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6843418/
https://ncbi.nlm.nih.gov/pubmed/31601022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom9100592
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!